RITZÉN, ANDREAS,KEHLER, JAN,LANGGÅRD, MORTEN,NIELSEN, JACOB,KILBURN, JOHN PAUL,FARAH, MOHAMED M.
申请号：
MYPI 2010006011
公开号：
MY152949A
申请日:
2009.06.19
申请国别(地区):
MY
年份:
2014
代理人:
摘要：
THIS INVENTION IS DIRECTED TO COMPOUNDS, WHICH ARE PDE10A ENZYME INHIBITORS. THE INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND OF THE INVENTION AND A PHARMACEUTICALLY ACCEPTABLE CARRIER. THE PRESENT INVENTION ALSO PROVIDES PROCESSES FOR THE PREPARATION OF THE COMPOUNDS OF FORMULA I. THE PRESENT INVENTION FURTHER PROVIDES A METHOD OF TREATING A SUBJECT SUFFERING FROM A NEURODEGENERATIVE DISORDER COMPRISING ADMINISTERING TO THE SUBJECT A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND OF FORMULA I. THE PRESENT INVENTION ALSO PROVIDES A METHOD OF TREATING A SUBJECT SUFFERING FROM A DRUG ADDICTION COMPRISING ADMINISTERING TO THE SUBJECT A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND OF FORMULA I. THE PRESENT INVENTION FURTHER PROVIDES A METHOD OF TREATING A SUBJECT SUFFERING FROM A PSYCHIATRIC DISORDER COMPRISING ADMINISTERING TO THE SUBJECT A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND OF FORMULA I. (NO SUITABLE FIGURE)
